![Cédric Bisson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Cédric Bisson is currently the Chairman at Procure and the Director at Iaculor Injection, Inc. He also holds the position of Director at Grand Challenges Canada, Northern Biologics, Inc., 35Pharma, Inc., and Associate at Teralys Capital, Inc. In the past, Dr. Bisson worked as a Director at Milestone Pharmaceuticals, Inc. and Mimetogen Pharmaceuticals, Inc. He was also the Managing Partner at iNovia Capital, Inc. from 2003 to 2010 and an Associate Principal at McKinsey & Co., Inc. (Canada).
Dr. Bisson holds a doctorate degree from McGill University and a graduate degree from the University of Montréal.
Posizioni attive di Cédric Bisson
| Società | Posizione | Inizio |
|---|---|---|
Teralys Capital, Inc.
 Teralys Capital, Inc. Investment ManagersFinance Teralys Capital is a technology-focused fund-of-funds that finances private venture capital funds. The firm focuses on funds that invest in information technology, the life sciences and clean technology companies. Their partner funds cover a range of opportunities including early-stage start-ups, expansion-stage, growth-stage and technology buyouts. They invest primarily in Quebec and Canada but also considers investments internationally. They make direct fund investments but they may also invest in a small percentage of secondary transactions. They partner with other private or international co-investors, either directly as investors in their own fund or as co-investors in their portfolio companies. | Investitore di Private Equity | 01/09/2011 |
Procure | Presidente | - |
Grand Challenges Canada
 Grand Challenges Canada Medical/Nursing ServicesHealth Services Provides support services for healthcare | Direttore/Membro del Consiglio | 04/05/2016 |
Iaculor Injection, Inc.
 Iaculor Injection, Inc. Medical SpecialtiesHealth Technology Develops needle free medical devices | Direttore/Membro del Consiglio | - |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Direttore/Membro del Consiglio | - |
35Pharma, Inc.
 35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Cédric Bisson
| Società | Posizione | Fine |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 05/03/2012 |
iNovia Capital, Inc.
 iNovia Capital, Inc. Investment ManagersFinance iNovia Capital invests in companies located in Canada & the United States. The firm targets companies operating in the fields of commerce, digital health, enterprise platforms, future of work, Security and travel & hospitality sectors. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 22/12/2010 |
McKinsey & Co., Inc. (Canada)
 McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Cédric Bisson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iNovia Capital, Inc.
iNovia Capital, Inc. Investment ManagersFinance iNovia Capital invests in companies located in Canada & the United States. The firm targets companies operating in the fields of commerce, digital health, enterprise platforms, future of work, Security and travel & hospitality sectors. It provides financing for seed and early stage capital requirements. | Finance |
Iaculor Injection, Inc.
Iaculor Injection, Inc. Medical SpecialtiesHealth Technology Develops needle free medical devices | Health Technology |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Health Technology |
Procure | |
Teralys Capital, Inc.
Teralys Capital, Inc. Investment ManagersFinance Teralys Capital is a technology-focused fund-of-funds that finances private venture capital funds. The firm focuses on funds that invest in information technology, the life sciences and clean technology companies. Their partner funds cover a range of opportunities including early-stage start-ups, expansion-stage, growth-stage and technology buyouts. They invest primarily in Quebec and Canada but also considers investments internationally. They make direct fund investments but they may also invest in a small percentage of secondary transactions. They partner with other private or international co-investors, either directly as investors in their own fund or as co-investors in their portfolio companies. | Finance |
McKinsey & Co., Inc. (Canada)
McKinsey & Co., Inc. (Canada) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Grand Challenges Canada
Grand Challenges Canada Medical/Nursing ServicesHealth Services Provides support services for healthcare | Health Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
35Pharma, Inc.
35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Health Technology |
